WO2005113043A1 - Medicament inhaler device - Google Patents

Medicament inhaler device Download PDF

Info

Publication number
WO2005113043A1
WO2005113043A1 PCT/GB2005/001979 GB2005001979W WO2005113043A1 WO 2005113043 A1 WO2005113043 A1 WO 2005113043A1 GB 2005001979 W GB2005001979 W GB 2005001979W WO 2005113043 A1 WO2005113043 A1 WO 2005113043A1
Authority
WO
WIPO (PCT)
Prior art keywords
device
chamber
body portion
composition
air
Prior art date
Application number
PCT/GB2005/001979
Other languages
French (fr)
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Limited
Wain, Christopher, Paul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IN570/MUM/2004 priority Critical
Priority to IN570MU2004 priority
Application filed by Cipla Limited, Wain, Christopher, Paul filed Critical Cipla Limited
Publication of WO2005113043A1 publication Critical patent/WO2005113043A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00Characteristics of a physical parameter; associated device therefor
    • A61M2206/10Flow characteristics
    • A61M2206/16Rotating swirling helical flow, e.g. by tangential inflows

Abstract

The present invention relates to apparatus for administering medicament and particularly, but not exclusively to apparatus for administering powdered or volatile composition by oral or nasal inhalation. The invention provides a device (2) comprising a body (4, 6) defining a chamber (48) for receiving composition to be inhaled; a mouthpiece (18) providing fluid communication to said chamber (48) and through which composition received in said chamber may, in use, be inhaled; and an air inlet (40, 42) providing fluid communication to said chamber (48) and through which air may, in use, be admitted into said chamber. The device is characterised by means for imparting a cyclonic motion onto air within said chamber.

Description

MEDICAMENT INHALER DEVICE

The present invention relates to apparatus for administering medicament and particularly, but not exclusively, to apparatus for administering powdered or volatile composition by oral inhalation.

Inhalers conventionally known in the art for administering doses of dry powdered medicament are generally designed for convenient handling and effective inhalation of the medicament dose. Inhalers for use with containers of dry powdered medicament are typically designed in such a way as to require a piercing of the container so that inhalation of the medicament can be effected. However, on continuous usage and cleaning of such devices, there often occurs operational difficulty as a result of rusting of the piercing mechanism which, in turn, results in an improper piercing of a container and decreases the efficiency of the drug delivery. It will be understood that the rusting of the piercing mechanism is a consequence of a frequent exposure of the piercing mechanism to cleaning solvents/agents and general moisture. Furthermore, as a consequence of piercing a container, fragmentation of a container shell results in a risk of inhalation of shell fragments.

Certain devices known in the art operate to break a container of medicament when parts of the device are rotated relative to one another. On inhalation by a patient, air travels through an inlet into a chamber wherein the air is redirected through 180° before passing through a mouthpiece.

Prior art document US 2003/0000523 Al discloses an inhaler device comprising an inhaler body defining a recess for receiving a container in which a substance to be inhaled is contained. A nosepiece communicating with the container is also provided together with a perforating element which is coupled to the inhaler body and provided for perforating the container so as to allow an outside air flow to be mixed with the container content and inhaled through the nosepiece. Prior art document EP 1 238 680 Bl discloses an inhaler device for dispensing powdered medicament contained in a container. The inhaler comprises a compartment for receiving a container and a cutting element for cutting or perforating the container and thereby releasing medicament contained within the container. The inhaler further comprises a grid for catching pieces of container while allowing passage of medicament to be inhaled. The inhaler may be equipped with disposable accessories to be placed into the mouth.

Prior art document EP 0 837 710 discloses a cartridge having an integrated metering device which comprises at least one metering cavity for receiving a predetermined quantity of pharmaceutical powder. The integrated metering device is capable of being moved out of a filling position into an emptying position approximately transversely with respect to the flow direction of the pharmaceutical powder. An inhaler is also disclosed for use with the cartridge.

It is an object of the present invention to provide an inhaler which is both inexpensive and convenient to manufacture and which ensures an effective dispensing of medicament upon inhalation by a user.

It is a further object of the present invention to provide an inhaler which is both simple in construction and simple to use.

A first aspect of the present invention provides a device as recited in the appended independent claim 1. A device comprising further novel and advantageous features is provided as recited in any of the appended dependent claims 2 to 21.

A second aspect of the present invention provides a device as recited in the appended independent claim 22. A device comprising further novel and advantageous features is provided as recited in any of the appended dependent claims 23 to 40. A device is described hereinafter for orally administering a composition by inhalation, the device comprising a body defining a chamber for receiving composition to be inhaled; a mouthpiece providing fluid communication to said chamber and through which composition received in said chamber may, in use, be inhaled; and at least one air inlet providing fluid communication to said chamber and through which air may, in use, be admitted into said chamber in response to an inhalation of composition through said mouthpiece; the device being characterised by means for imparting a cyclonic motion onto air within said chamber.

It will be understood therefore that, through use of the present invention, medicament composition received in said chamber will, upon inhalation by a user, be exposed to an air flow having a cyclonic motion. This particular motion ensures that a high proportion of medicament within said chamber becomes entrained in the air flow passing through said chamber and into the mouthpiece. The cyclonic motion thereby ensures that an improved level of medicament is inhaled as compared with prior art devices.

Ideally, said cyclonic motion means imparts cyclonic motion onto air immediately as said air enters said chamber. It is also preferable for said cyclonic motion means to comprise said air inlet. Said air inlet may be oriented so as to admit air into said chamber in a direction skewed. Also, said air inlet may extend through a side wall of said chamber and said cyclonic motion may comprise a curved surface defining said chamber. It is also desirable for said body to comprise first and second portions each having a cylindrical member, the cylindrical member of the second body portion being telescopically received in the cylindrical member of the first body portion. Furthermore, said air inlet may be defined by an aperture in said first body portion and an end of the cylindrical member of the second body portion which locates adjacent said aperture. Means may be provided on the first body portion for holding a container of composition within said chamber. Also, an abutment member may be provided on the second body portion, the abutment member being located so that, in use, a container of composition held in said container holding means and projecting therefrom into said chamber is engaged by the abutment member when the first and second body portions are rotated relative to one another, the engagement assisting with release of composition from the container of composition. The abutment member is ideally located in the cylindrical member of the second body portion.

Also, grate means may be provided for restricting entry into the mouthpiece of a container of composition. Furthermore, said cyclonic motion means may generate a vortex which, as a whole, passes along a generally circular or part circular path within said chamber. In other words, the vortex is itself deflected along a generally circular or part circular path. As a result, a primary current (a flow passing along the circular or part circular path) and a secondary current (the vortex) are generated. The term vortex will be readily understood by a person skilled in the art and refers to a swirling body of fluid.

The present invention thereby provides the advantage over the prior art of enhanced effectiveness in dispensing medicament by inhalation.

Embodiments of the present invention will now be described with reference to the accompanying drawings, in which:

Figure 1 is a cross-sectional side view of an inhaler device according to the present invention;

Figure 2 is a front view of a top body portion of the inhaler device of Figure 1;

Figure 3 is a side view of the top body portion of Figure 2;

Figure 4 is a top view of the top body portion of Figure 2;

Figure 5 is a top view of a bottom body portion of the inhaler device of Figure 1 ; Figure 6 is a cross-sectional side view of the bottom body portion taken along line A- A of Figure 5.

Figure 7 is a cross-sectional side view of a modified version of the inhaler shown in Figure 1 ; and

Figure 8 is a top view of a bottom body portion of the modified inhaler of Figure 7.

A cross-sectional side view of an inhaler device 2 according to the present invention is shown in Figure 1 of the accompanying drawings. The device 2 comprises an upper body portion 4 and a lower body portion 6. A cylindrical wall 8 of the upper body portion 4 receives a cylindrical wall 10 of the lower body portion 6. The relative dimensions of the cylindrical walls 8, 10 are such that the upper and lower body portions 4, 6 securely engage one another without undue play whilst allowing the body portions 4, 6 to be rotated relative to one another. The upper and lower body portions 4, 6 are retained in their assembled positions relative to one another as shown in Figure 1 by means of one or more clip members which locate in a recess. The or each clip member 12 is provided on one of the first and second body portions 4, 6 for removably locating in the recess 14 which is provided in the- other of the first and second body portions 4, 6. In the inhaler device 2, three clip members 12 are provided equidistant circumferentially along the cylindrical wall 8 of the upper body portion 4 and extend radially inwardly into a circumferentially extending recess 14 provided in the exterior surface of the cylindrical wall 10 of the lower body portion 6. The lower body portion 6 is thereby retained in a desired axial position relative to the upper body portion 4 with relative rotation of the two portions 4, 6 being unrestricted. In an alternative embodiment (not shown), the three clip members are provided on the lower body portion 6 and the circumferentially extending recess 14 is provided in the upper body portion 4. The lower body portion 6 further comprises a dish-shaped wall 16 (U-shaped in cross-section) which is circumferentially joined to the cylindrical wall 10 of the lower body portion 6. The dish-shaped wall 16 thereby closes the longitudinal bore formed by the cylindrical wall 10. In use, the dish-shaped wall 16 acts to cradle medicament fallen from a container of medicament. In an alternative embodiment, the wall 16 is planar (i.e. flat rather than dish-shaped.

As can be seen from Figures 5 and 6 of the accompanying drawings, the lower body portion 6 further comprises an abutment member 20 which is located adjacent an upper edge 22 of the lower body portion 6 and which extends a short distance radially inwards from the outer perimeter of the dish-shaped wall 16. As will be understood from the forthcoming description, the abutment member 20 need only extend a sufficient distance to ensure it engages with a container of medicament projecting into the lower body portion 6 from a container holder 24. The purpose of the abutment member 20 is to abut such a container upon relative rotation of the two body portions 4, 6 and, upon further rotation, to open the container and thereby release medicament held therein. As such, the abutment member 20 must have sufficient structural integrity to open a container without itself becoming damaged.

It will be understood with reference to Figure 1 of the accompanying drawings that the section of cylindrical wall 10 located below the circumferential recess 14 is, in use, held by a patient to assist in rotating the lower body portion 6 relative to the upper body portion 4 and thereby opening a container to release medicament to be inhaled.

With reference to Figures 2 to 4 of the accompanying drawings, it will be seen that the upper body portion 4 comprises a cylindrical wall 8 which is closed, at least in part, by a stepped transversely extending wall. The stepped wall comprises an outer annular part 26 extending inwardly from the cylindrical wall 8, and further comprises a circular part 28 joining the annular part by means of an upward step 30.

An outlet aperture 32 is provided in the circular part 28. A grate 34 covers the outlet aperture 32 so as to allow a passage of air and medicament therethrough but to prevent the passage of a medicament container. A mouthpiece tube 18 having an oval-section extends upwardly from the circular part 28 and surrounds the outlet aperture 32.

A medicament container inlet aperture 36 is also provided in the circular part 28 for receiving and holding a container containing medicament to be inhaled. A tubular member 38 surrounds the container aperture 36 and, in use, surrounds and protects a container held in the container aperture 36 and extending upwardly from the circular part 28.

Two inlet apertures 40 are provided in the annular part 26 of the upper body portion 4 and are located diametrically opposite to one another (see Figures 2 and 4). With reference to Figure 1 of the accompanying drawings, it will be understood that the upper edge 22 of the lower body portion 6 is in abutment with or in close proximity to the annular part 26 of the upper body portion 4. As such, the upper edge 22 of the lower body portion 6 overlies the apertures 40. At least a part of the upper edge 22 may extend radially from a radially outer edge of each aperture 40 to a radially inner edge of each aperture 40 so as to overlie the whole of each aperture 40. As will be understood from the following description, when the upper edge 22 abuts the upper body portion 4 and wholly overlies the apertures 40, all air entering the inhaler is admitted via grooves 42 extending from the apertures 40.

Also, the radial dimension of the upper edge 22 may be insufficient to extend from a radially outer edge of an inlet aperture 40 to a radially inner edge of the aperture 40. In one embodiment (not shown), the upper edge 22 of the lower body portion 6 does not extend radially inwardly to the radially inner edges of the apertures 40 and, as a consequence, a radially inward area of the apertures 40 provides a flow path, for some of the incoming air, directly into the inhaler device. This alternative arrangement can advantageously generate a vortex flow of air by encouraging (through use of said radially inward area of the apertures) incoming air to enter the chamber over the upper edge 22.

Regardless of whether or not the upper edge 22 extends radially across the whole of the apertures 40, a groove 42 extending from each aperture 40 is provided in the underside 44 of the annular part 26. Each groove 42 extends from the associated inlet aperture 40 to the radially inward edge of the annular part 26 so as to provide a flow path into the inhaler device 2 between the adjacent upper and lower body portions 4, 6. Each groove 42 extends tangentially relative to the longitudinal axis 46 of the inhaler device 2. As such, it will be understood that air admitted into the inhaler device 2 flows into the inlet apertures 40 in a tangential direction along the circular wall formed by the step 30 between the annular and circular parts 26, 28 of the upper body portion 4. The inlet apertures 40 in combination with the grooves 42 and circular wall 30 thereby cooperate to provide a cyclonic flow of air within the inhaler device 2. It will however be appreciated that the grooves 42 may be arranged with a different orientation to that shown and described herein so that a cyclonic air flow having a different flow characteristic is generated. In the case where the upper edge 22 of the lower body portion 6 does not extend to the radially inner edges of the inlet apertures 40, a flow of air about the longitudinal axis 46 of the inhaler 2 may be generated which itself is swirling as a vortex about the tangential direction of flow.

The device may be manufactured from any suitable material, for example, any suitable plastics material.

In use of the inhaler 2, the upper and lower body portions 4, 6 are firstly separated so as to empty the inhaler of the medicament container. The two body portions 4, 6 are then reassembled with the clip members 12 resiliently snap fitting into the circumferential recess 14 (see Figure 1). A chamber 48 is thereby defined between the dish-shaped wall 16 and the annular part 26, circular part 28 and step 30. The inhaler device 2 is then loaded with a container of medicament by placing the container (not shown in the accompanying drawings) into the tube 38. The container is held by the container aperture 36 and is thereby prevented from dropping into the chamber 48. The length of the container tube 38 is such that, when the container is pushed into the container aperture 36 so that the upper end of the container is level with the upper end of the container tube 38, the lower end of the container extends into the lower body portion 6 so as to be engageable by the abutment member 20. The upper and lower body portions 4, 6 are then grasped by the user and rotated relative to one another so that the abutment member 20 engages and opens the container. Medicament contained in the container is thereby released into the chamber 48.

Once medicament has been released into the chamber 48, the user places the mouthpiece 18 into the mouth so that air may be inhaled via the chamber 48. As the user inhales, air is admitted into the chamber 48 through the inlet apertures 40. As will be understood from the above description, means are provided for imposing a cyclonic motion onto air admitted into the chamber 48. The resulting cyclonic motion within the chamber 48 ensures that medicament released into the chamber 48 from the opened medicament container is effectively entrained into the air flow entering the mouthpiece 18. Whilst the grate 34 allows the passage of air and entrained medicament therethrough, the apertures forming the grate 34 are sufficiently small to prevent passage of the medicament container which may fall into the chamber 48 upon opening or subsequently during inhalation.

The chamber 48 has a volume of such a size that, in use, upon a single inhalation through the chamber by a patient, the medicament within the chamber is inhaled by the patient. The volume of the chamber 48 is such that, on inhalation by a patient, a fluid pressure drop is induced at the point of inhalation. In comparison to a prior art inhaler, at a constant pressure drop of 4kPa, the flow rate in the prior art inhaler is 45 litres per minute (1/min) whereas the flow rate in the present inhaler device 2 is 60 1/min. Movement of the air within the chamber is thereby induced and this results in a suspension of medicament particles within the air inhaled by the patient.

In comparison to a prior art inhaler, the volume of the chamber of the present device 2 is smaller than the volume of the chamber of the prior art inhaler. This smaller volume also contributes to improving the performance of the device.

The volume of the chamber of the present device 2 may preferably be from 1611 mm3 to 6444 mm3.

Once the dose of medicament within the chamber 48 has been inhaled, the upper and lower body portions 4, 6 may be separated and the chamber 48 emptied before reassembly and loading with a fresh container.

The following cascade data illustrates the improved performance of the inhaler of Figures 1 to 6 over a prior art inhaler.

Figure imgf000012_0001
The cascade analysis gives a value of Fpd (Fine particle dose) / % Fpf (fine particle fraction) which gives a value of particles which have probability of reaching the lungs.

The test was done according to USP using Cascade impactor.

The present invention is not limited to the specific embodiments described above. Alternative arrangements will be apparent to a reader skilled in the art. For example, a cover may be provided for closing the mouthpiece 18. The cover may be integral with one of the body portions 4, 6 or may be a separate component. Furthermore, the cover may have a generally cylindrical shape with one end thereof closed by a transversely extending wall, the diameter of the cylinder being approximately the same as that of the cylindrical wall 8 of the upper body portion 4. This cover may resiliently snap fit to the cylindrical wall 8 and extend upwardly therefrom so as to cover both the mouthpiece 18 and the container tube 38. The primary purpose of the cover is to prevent dust from entering the inhaler device. Alternative arrangements of cover will be apparent to a skilled person.

Also, the mouthpiece and/or the means for receiving and holding a medicament container may be removably secured to the remainder of the inhaler. This may be achieved by means of a releasable connection such as that provided by interengaging screw threads or a snap fit or interference fit connection. Furthermore, the interior of the mouthpiece may be provided with a guide vane 100 (for example, a helical or spiral ramp) which has the effect of imparting, inducing or maintaining a cyclonic flow in air inhaled therethrough (see Figure 7). Guide vanes 102 may also be provided in the chamber 48 for encouraging incoming air to follow a cyclonic path or for inducing or maintaining a cyclonic flow in the incoming air. The guide vanes 102 may have a cylindrical or part- cylindrical shape and may be mounted by suitable means 104 (for example, one or more slender rod) to the lower body portion 6 (see Figures 7 and 8).

Claims

CLAIMS:
1. A device for orally administering a composition by inhalation, the device comprising a body defining a chamber for receiving composition to be inhaled; a mouthpiece providing fluid communication to said chamber and through which composition received in said chamber may, in use, be inhaled; and at least one air inlet providing fluid communication to said chamber and through which air may, in use, be admitted into said chamber in response to an inhalation of composition through said mouthpiece; the device being characterised by means for imparting a cyclonic motion onto air within said chamber.
2. A device as claimed in claim 1, wherein said cyclonic motion means imparts cyclonic motion onto air immediately as said air enters said chamber.
3. A device as claimed in claim 1 or 2, wherein said cyclonic motion means comprises the or each air inlet.
4. A device as claimed in claim 3, wherein two of said air inlets are positioned on diametric opposite sides of said chamber.
5. A device as claimed in any of the preceding claims, wherein the or each air inlet extends through a side wall of said chamber.
6. A device as claimed in any of the preceding claims, wherein said cyclonic motion means comprises a curved surface defining said chamber.
7. A device as claimed in any of the preceding claims, wherein said cyclonic motion means comprises at least one groove which is provided in said body and which extends from at least one of said air inlets.
8. A device as claimed in any of the preceding claims, , wherein said cyclonic motion means comprises a groove extending from the or each of said air inlets, each groove being provided in said body.
9. A device as claimed in claim 7 or 8, wherein the or each groove extends from one of said air inlets in a tangential direction relative to a longitudinal axis of the device.
10. A device as claimed in any of the preceding claims, wherein said body comprises first and second portions each having a cylindrical member, the cylindrical member of the second body portion being telescopically received in the cylindrical member of the first body portion.
11. A device as claimed in claim 10, wherein at least one air inlet is defined by an aperture in said first body portion and an end of the cylindrical member of the second body portion which locates adjacent said aperture.
12. A device as claimed in claim 10 or 11 when dependent on any of claims 7 to 9, wherein the or each groove is provided in an annular part of said first body portion, and preferably, wherein the or each groove is provided in the underside of the annular part of said first body portion
13. A device as claimed in claim 10, 11 or 12, comprising means provided on the first body portion for holding a container of composition within said chamber.
14. A device as claimed in claim 13, comprising an abutment member provided on the second body portion, the abutment member being located so that, in use, a container of composition held in said container holding means and projecting therefrom into said chamber is engaged by the abutment member when the first and second body portions are rotated relative to one another, the engagement assisting with release of composition from the container of composition.
15. A device as claimed in claim 14, wherein the abutment member is located in the cylindrical member of the second body portion.
16. A device as claimed in any of the preceding claims, wherein grate means are provided for restricting entry into the mouthpiece of a container of composition.
17. A device as claimed in any of the preceding claims, wherein said cyclonic motion means generates a secondary current within a primary current of air passing along a generally circular or part circular path within said chamber.
18. A device as claimed in any of the preceding claims, wherein said mouthpiece is removably attached to said body.
19. A device as claimed in any of the preceding claims, wherein means for holding a container of composition within said chamber is removably attached to said body.
20. A device as claimed in any of the preceding claims, wherein said chamber has a volume of such a size that, in use, upon a single inhalation through the chamber by a patient, the medicament within the chamber is inhaled by the patient.
21. A device as claimed in claim 20, wherein the volume of the chamber is from 1611 mm3 to 6444 mm3.
22. A device for orally administering a composition by inhalation, the device comprising a body defining a chamber for receiving composition to be inhaled wherein said chamber has a volume of such a size that, in use, upon a single inhalation through the chamber by a patient, the medicament within the chamber is inhaled by the patient.
23. A device as claimed in claim 22, wherein the volume of the chamber is from 1611 mm3 to 6444 mm3.
24. A device as claimed in any of claim 22 or 23, further comprising a mouthpiece providing fluid communication to said chamber and through which composition received in said chamber may, in use, be inhaled.
25. A device as claimed in claim 24, further comprising at least one air inlet providing fluid communication to said chamber and through which air may, in use, be admitted into said chamber in response to an inhalation of composition through said mouthpiece; and means for imparting a cyclonic motion onto air within said chamber.
26. A device as claimed in claim 25, wherein said body comprises first and second portions each having a cylindrical member, the cylindrical member of the second body portion being telescopically received in the cylindrical member of the first body portion.
27. A device as claimed in claim 26, comprising means provided on the first body portion for holding a container of composition within said chamber.
28. A device as claimed in claim 27, comprising an abutment member provided on the second body portion, the abutment member being located so that, in use, a container of composition held in said container holding means and projecting therefrom into said chamber is engaged by the abutment member when the first and second body portions are rotated relative to one another, the engagement assisting with release of composition from the container of composition.
29. A device as claimed in claim 28, wherein the abutment member is located in the cylindrical member of the second body portion.
30. A device as claimed in any of the preceding claims, further comprising a guide vane for inducing or maintaining a cyclonic flow.
31. A device as claimed in claim 30, wherein said guide vane is provided in said chamber.
32. A device as claimed in claim 31, wherein said guide vane has a cylindrical or part-cylindrical shape.
33. A device as claimed in any of the preceding claims, wherein a mouthpiece, which provides fluid communication with said chamber and through which composition received in said chamber may in use be inhaled, is provided with a guide vane for inducing or maintaining a cyclonic flow.
34. A device as claimed in claim 33, wherein said guide vane provided in the mouthpiece has a helical or spiral shape.
35. A device as claimed in any of the preceding claims, wherein a first body portion (4) comprises a cylindrical wall (8) having an annular part (26) extending inwardly from the cylindrical wall.
36. A device as claimed in claim 35 wherein the first body portion (4) further comprises a circular part (28) joining the annular part (26) by means of an upward step (30).
37. A device as claimed in claim 35 or 36, wherein the second body portion (6) has an upper edge (22) in abutment with the annular part (26) of the first body portion (4) such that the upper edge (22) of a second body portion over lies at least one air inlet aperture (40) on the first body portion (4).
38. A device as claimed in any of the preceding claims, further comprising a clip member (12) provided on one of first and second body portions (4, 6) for removably locating in a recess (14) provided in the other of the first and second body portions (4, 6).
39. A device as claimed in claim 38, wherein said recess (14) for receiving said clip member (12) is circumferentially extending so as to allow rotatable engagement of the first and second body portions (4, 6).
40. A device as claimed in any of the preceding claims, wherein an upper edge (22) of a lower body portion (6) extends radially inwardly to only partially cover each inlet aperture (40) so that a flow of air about a longitudinal axis is generated which is itself swirling as a vortex about a tangential direction of flow.
PCT/GB2005/001979 2004-05-19 2005-05-19 Medicament inhaler device WO2005113043A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN570/MUM/2004 2004-05-19
IN570MU2004 2004-05-19

Publications (1)

Publication Number Publication Date
WO2005113043A1 true WO2005113043A1 (en) 2005-12-01

Family

ID=34956626

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2005/001979 WO2005113043A1 (en) 2004-05-19 2005-05-19 Medicament inhaler device

Country Status (7)

Country Link
AR (1) AR052759A1 (en)
PA (1) PA8633401A1 (en)
PE (1) PE00702006A1 (en)
SV (1) SV2007002120A (en)
TW (1) TW200607538A (en)
UY (1) UY28908A1 (en)
WO (1) WO2005113043A1 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011020554A1 (en) * 2009-08-18 2011-02-24 Gamptec Gmbh Inhalation device and method for inhaling an active ingredient from a capsule
US8912193B2 (en) 2008-06-13 2014-12-16 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9393372B2 (en) 2008-06-13 2016-07-19 Mannkind Corporation Dry powder drug delivery system
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319265D0 (en) * 2013-10-31 2013-12-18 Norton Waterford Ltd Medicament inhaler

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423724A (en) * 1980-06-06 1984-01-03 Fisons Limited Inhalation device for powdered medicaments
US4907583A (en) * 1986-03-07 1990-03-13 Aktiebolaget Draco Device in powder inhalators
WO1991019524A2 (en) * 1990-06-14 1991-12-26 Rhone-Poulenc Rorer Limited Inhaler
WO1998026828A2 (en) * 1996-12-18 1998-06-25 Custom Focus Limited Medicament delivery and packaging
US20020033177A1 (en) * 1999-01-27 2002-03-21 Hisatomo Ohki Inhalant medicator
US20030000523A1 (en) * 2001-06-28 2003-01-02 Mauro Citterio Inhaler device

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423724A (en) * 1980-06-06 1984-01-03 Fisons Limited Inhalation device for powdered medicaments
US4907583A (en) * 1986-03-07 1990-03-13 Aktiebolaget Draco Device in powder inhalators
WO1991019524A2 (en) * 1990-06-14 1991-12-26 Rhone-Poulenc Rorer Limited Inhaler
WO1998026828A2 (en) * 1996-12-18 1998-06-25 Custom Focus Limited Medicament delivery and packaging
US20020033177A1 (en) * 1999-01-27 2002-03-21 Hisatomo Ohki Inhalant medicator
US20030000523A1 (en) * 2001-06-28 2003-01-02 Mauro Citterio Inhaler device

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9393372B2 (en) 2008-06-13 2016-07-19 Mannkind Corporation Dry powder drug delivery system
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8912193B2 (en) 2008-06-13 2014-12-16 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
EA032404B1 (en) * 2009-08-18 2019-05-31 Гамптек Гмбх Inhalation device and method for inhaling an active ingredient from a capsule
CN102573970A (en) * 2009-08-18 2012-07-11 盖木普科技有限责任公司 Inhalation device and method for inhaling an active ingredient from a capsule
WO2011020554A1 (en) * 2009-08-18 2011-02-24 Gamptec Gmbh Inhalation device and method for inhaling an active ingredient from a capsule
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin

Also Published As

Publication number Publication date
PA8633401A1 (en) 2006-09-08
AR052759A1 (en) 2007-04-04
UY28908A1 (en) 2005-12-30
SV2007002120A (en) 2007-02-26
TW200607538A (en) 2006-03-01
PE00702006A1 (en) 2006-02-18

Similar Documents

Publication Publication Date Title
EP1658872B1 (en) Powder inhaler
AU666979B2 (en) Powder inhaler
JP3747076B2 (en) Pharmaceutical inhalation devices
CN101554504B (en) Unit dose cartridge and dry powder inhaler
CA1115613A (en) Device for dispensing medicaments
JP4115531B2 (en) Inhaler
CA1169322A (en) Powder inhalation device
KR100269060B1 (en) Pharmaceutical powder cartrige with integrated metering device inhaler for powdered medicaments
KR101324023B1 (en) Nasal delivery devices
RU2106881C1 (en) Inhaler
CA2444129C (en) Inhalation device and method
US5529059A (en) Inhalation devices
CN101415457B (en) Powder inhaler featuring disc with dosing holes
CA2147260C (en) Dry powder inhaler
JP4340162B2 (en) Powder inhaler
AU2001284643B2 (en) De-agglomerator for breath-actuated dry powder inhaler
JP5831949B2 (en) Inhaler
EP0503031B1 (en) Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber
US6550477B1 (en) Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
US5595175A (en) Inhaler for administration of powdery substances
CA2369722C (en) Powder inhaler for combined medicament
RU2536251C2 (en) Simple capsular inhaler
EP1294420B2 (en) Pre-metered dose magazine for breath-actuated dry powder inhaler
EP1894591A2 (en) Inhalation apparatus
US5699789A (en) Dry powder inhaler

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWW Wipo information: withdrawn in national office

Ref document number: DE

NENP Non-entry into the national phase in:

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1447/MUMNP/2006

Country of ref document: IN

122 Ep: pct application non-entry in european phase